A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution

Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)

NCT00600288 ·Status: COMPLETED ·Phase: PHASE3

The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)

NCT00831662 ·Status: COMPLETED ·Phase: PHASE3

Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease

NCT05586152 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants

NCT05992922 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of the Safety, Tolerability and Efficacy of iNexin™ for the Treatment of the Signs and Symptoms Associated With Dry Eye Disease

NCT05031806 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

NCT06766357 ·Status: RECRUITING ·Phase: PHASE3

Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients

NCT05245604 ·Status: UNKNOWN ·Phase: PHASE3

Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

NCT01101984 ·Status: COMPLETED ·Phase: NA

Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group

NCT01768312 ·Status: COMPLETED ·Phase: PHASE3

Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease

NCT06370039 ·Status: COMPLETED ·Phase: PHASE2

A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients

NCT01468168 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

NCT02004067 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation

NCT00349583 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes

NCT01804361 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)

NCT02121301 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of TOP1630 for Dry Eye Syndrome

NCT03088605 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye

NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study of SkQ1 as Treatment for Dry-eye Syndrome

NCT03764735 ·Status: COMPLETED ·Phase: PHASE3

Ditefossol Sodium 3% Eye Drops in Patients With Dry Eye

NCT06560580 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease

NCT05238597 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome

NCT01670357 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye

NCT03982368 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops

NCT00001731 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease

NCT00758784 ·Status: COMPLETED ·Phase: PHASE2

Study of TOP1630 for Dry Eye Syndrome

NCT03833388 ·Status: COMPLETED ·Phase: PHASE2/PHASE3